Last month, I had the opportunity to attend Dassault Systèmes’ analyst conference at the company’s headquarters in Vélizy, France, just outside Paris. There, I was briefed by company executives on Dassault’s Life Sciences strategy.
My most memorable experience at the conference was that of hovering through the human heart. While Dassault scientists have not yet devised a way to miniaturize matter by shrinking individual atoms, like in Fantastic Voyage, they have achieved the next best thing. Continue reading